Leerink Reaffirms Neovasc (NVCN) at 'Outperform' Amid Boston Scientific Deal
Go back to Leerink Reaffirms Neovasc (NVCN) at 'Outperform' Amid Boston Scientific Deal| Boston Scientific (NYSE: BSX) | Delayed: 50.37 +1.00 (2.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.37 | 52 Week High | $24.79 | |||
| Open | $49.22 | 52 Week Low | $15.67 | |||
| Day High | $50.90 | P/E | N/A | |||
| Day Low | $49.01 | EPS | $-0.09 | |||
| Volume | 35,991,883 | |||||
| (NASDAQ: NVCN) | Delayed: 30.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.03 | 52 Week High | $5.04 | |||
| Open | $4.36 | 52 Week Low | $0.37 | |||
| Day High | $30.03 | P/E | N/A | |||
| Day Low | $30.03 | EPS | $0.00 | |||
| Volume | 350,983 | |||||

